Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

NCT02833792 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Dementia

Interventions

DRUG: Human Mesenchymal Stem Cells and Lactated Riunger's Solution
OTHER: Placebo

Sponsor

Stemedica Cell Technologies, Inc.

Collaborators

[object Object]